Correlation Between Denali Therapeutics and Benitec Biopharma
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Benitec Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Benitec Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Benitec Biopharma Ltd, you can compare the effects of market volatilities on Denali Therapeutics and Benitec Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Benitec Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Benitec Biopharma.
Diversification Opportunities for Denali Therapeutics and Benitec Biopharma
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Denali and Benitec is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Benitec Biopharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Benitec Biopharma and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Benitec Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Benitec Biopharma has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Benitec Biopharma go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Benitec Biopharma
Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Benitec Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 1.11 times less risky than Benitec Biopharma. The stock trades about -0.03 of its potential returns per unit of risk. The Benitec Biopharma Ltd is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 976.00 in Benitec Biopharma Ltd on November 2, 2024 and sell it today you would earn a total of 173.00 from holding Benitec Biopharma Ltd or generate 17.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Benitec Biopharma Ltd
Performance |
| Timeline |
| Denali Therapeutics |
| Benitec Biopharma |
Denali Therapeutics and Benitec Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Benitec Biopharma
The main advantage of trading using opposite Denali Therapeutics and Benitec Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Benitec Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Benitec Biopharma will offset losses from the drop in Benitec Biopharma's long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Benitec Biopharma vs. Bio Path Holdings | Benitec Biopharma vs. Capricor Therapeutics | Benitec Biopharma vs. NextCure | Benitec Biopharma vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |